Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: SJM stock price vs CL: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at CL's multiple
Needs CL P/S.
Implied fair value · at SJM's multiple
Needs SJM P/S.
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
Nine period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
The J. M. Smucker Company · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
COLGATE-PALMOLIVE COMPANY · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
COCA COLA CO
SJM vs KO
PEPSICO INC
SJM vs PEP
GENERAL MILLS INC
SJM vs GIS
Lamb Weston Holdings, Inc.
SJM vs LW
HORMEL FOODS CORP /DE/
SJM vs HRL
PROCTER & GAMBLE Co
SJM vs PG
JOHNSON & JOHNSON
SJM vs JNJ
CHURCH & DWIGHT CO INC /DE/
SJM vs CHD
KIMBERLY CLARK CORP
SJM vs KMB
EDGEWELL PERSONAL CARE Co
SJM vs EPC
UNILEVER PLC
SJM vs UL
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe SJM can materially improve margins and reduce leverage enough to justify a much higher earnings multiple, then consider the stock; otherwise, CL appears the higher-quality relative valuation choice because its superior profitability, returns, and balance sheet resilience better support its premium valuation.
On the provided P/S anchor, SJM screens with an implied price of $303.01 versus a current price of $119.26, implying 154.1% upside, but that result is hard to reconcile with the company’s weaker operating profile versus CL. SJM also sits well above its DCF range of $9.41-$12.73 and only modestly above the top of its historical band at $131.19, suggesting the headline multiple-based upside is not supported by other valuation frameworks.
Supporting Metrics
